The WHO R&D Blueprint: 2018 review of emerging infectious diseases requiring urgent research and development efforts.
Ontology highlight
ABSTRACT: The Research and Development (R&D) Blueprint is a World Health Organization initiative to reduce the time between the declaration of a public health emergency and the availability of effective diagnostic tests, vaccines, and treatments that can save lives and avert a public health crisis. The scope of the Blueprint extends to severe emerging diseases for which there are insufficient or no presently existing medical countermeasures or pipelines to produce them. In February 2018, WHO held an informal expert consultation to review and update the list of priority diseases, employing a prioritization methodology which uses the Delphi technique, questionnaires, multi-criteria decision analysis, and expert review to identify relevant diseases. The committee determined that, given their potential
SUBMITTER: Mehand MS
PROVIDER: S-EPMC7113760 | biostudies-literature | 2018 Nov
REPOSITORIES: biostudies-literature
ACCESS DATA